Cargando…

Primary basal cell carcinoma of the prostate with concurrent adenocarcinoma

INTRODUCTION: Prostatic basal cell carcinoma is an extremely rare tumor, exhibiting various histopathological features and clinical spectrums of disease. CASE PRESENTATION: A 69‐year‐old male presented to our department with 2 years of voiding difficulty and intermittent macroscopic hematuria. With...

Descripción completa

Detalles Bibliográficos
Autores principales: Hennes, David, Dragovic, Adrian, Sewell, James, Hoh, Meng Yeong, Grills, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292061/
https://www.ncbi.nlm.nih.gov/pubmed/32743470
http://dx.doi.org/10.1002/iju5.12143
Descripción
Sumario:INTRODUCTION: Prostatic basal cell carcinoma is an extremely rare tumor, exhibiting various histopathological features and clinical spectrums of disease. CASE PRESENTATION: A 69‐year‐old male presented to our department with 2 years of voiding difficulty and intermittent macroscopic hematuria. With a presumed diagnosis of benign prostatic hyperplasia, he underwent a transurethral resection of the prostate. Pathological examination revealed atypical basaloid cells forming solid nests. Robot‐assisted radical prostatectomy was subsequently performed, confirming a diagnosis of basal cell carcinoma with coexisting acinar adenocarcinoma. CONCLUSION: Although more cases of basal cell carcinoma are indolent than aggressive, there is no reliable method of differentiation between these presentations. Thus, we recommend radical surgery and 6‐monthly disease surveillance until more is discovered about this very rare malignancy.